Physician profile
Hannah Lai
NPI 1609170844
$4,627.77
in general payments reported to CMS, 2019-2025
41 companies · $731 in 2025
The $731 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $244 · 2021: $141 · 2022: $466 · 2023: $1,095 · 2024: $942 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.08 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $725.58 | 2019-2025 | Wegovy, Saxenda, Ozempic |
| Amgen INC. | $551.03 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $541.41 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $270.47 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.49 | 2019-2024 | Ofev |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.29 | 2023-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $201.90 | 2022-2025 | Stelara, Simponi Aria, Simponi |
| Abbott Laboratories | $161.31 | 2020-2024 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $158.33 | 2019-2025 | |
| Astellas Pharma US INC | $154.70 | 2019-2025 | Veozah, Myrbetriq |
| Actelion Pharmaceuticals US, INC. | $149.01 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.37 | 2022-2023 | |
| Boston Scientific Corporation | $83.92 | 2022-2025 | Watchman Flx |
| Alkermes, INC. | $80.91 | 2019 | |
| Qol Medical, LLC | $77.72 | 2022-2025 | Sucraid, Sucraid |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.